This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

Exact Sciences stockholders approve acquisition by Abbott

( February 20, 2026, 15:30 GMT | Official Statement) -- MLex Summary: Exact Sciences, a provider of cancer screening and diagnostic tests, said its stockholders approved its proposed sale to Abbott. At a special meeting of stockholders, preliminary results showed that more than 99 percent of votes cast, representing about 67 percent of the total outstanding shares as of Jan. 9, 2026, voted in favor of the merger. Statement follows in full. ...

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login